Neoral monitoring 2 hours post-dose and the pediatric transplant patient

Pediatric Transplantation

Volumn 7, Issue 1, 2003, Pages 25-30

  Dunn, Stephen P ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

C 2; Neoral; Pediatric

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG MONITORING; DRUG USE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MICROEMULSION; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; REVIEW;

CHILD; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; EMULSIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION;

EID: 0037295326     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2003.02040.x     Document Type: Review

References (30)

1. CALNE RY, WHITE DJ, THIRU S, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978: 2: 1323-1327.
2. HARIHARAN S, JOHNSON CP, BRESNAHAN BA, TARANTO SE, MCINTOSH MJ, STABLEIN D. Improved graft survival after renal transplantation in the United States. N Engl J Med 2000: 342: 605-612.
3. KAHAN BD. Cyclosporine. N Engl J Med 1989: 321: 1725-1738.
4. LINDOLM A, KAHAN BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993: 54: 205-218.
5. HALLORAN PF, HELMS LMH, KUNG L, NOUJAIM J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999: 68: 1356-1361.
6. LEVY GA. C2 monitoring strategy for optimising cyclosporine immunosuppression from the Neoral formulation. BioDrugs 2001: 15: 279-290.
7. MAHALATI K, BELITSKY P, KIBERD B, et al. Absorption profiling - a novel method for monitoring Neoral in kidney transplantation that reduces rejection and nephrotoxicity. Transplantation 2000: 69: S114 (Abstr. 12).
8. BELITSKY P, DUNN S, JOHSTON A, et al. Impact of absorption profiling on efficacy and safety of cyclosporine therapy in transplant recipients. Clin Pharmacokinet 2000: 39: 117-125.
9. KEOWN P, FOR THE CANADIAN NEORAL RENAL TRANSPLANTATION STUDY GROUP. Absorption profiling of cyclosporin microemulsion (Neoral) during the first two weeks after renal transplantation. Transplantation 2001: 72: 1024-1032.
10. BARAMA A, PERNER F, BEAUREGARD-ZOLLINGER L, et al., FOR THE NEORAL PHASE IV STUDY GROUP. Absorption profiling of cyclosporine therapy for de novo kidney transplantation: A prospective randomized study comparing sparse sampling to trough monitoring. Transplantation 2000: 69 (Suppl.): S162 [Abstr. 190].
11. LEVY GA, LAKE JR, BEAUREGARD-ZOLLINGER L, et al., FOR THE PHASE IV STUDY GROUP. Improved clinical outcomes for liver transplant recipients using cyclosporine blood level monitoring based on two-hour post-dose levels. Transplantation 2000: 69 (Suppl.): S387 (Abstr. no. 1059).
12. KAHAN BD. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation 1985: 40: 457-476.
13. KAHAN BD, WALSH M, SCHOENBERG L, et al. Variable oral absorption of cyclosporine: A biopharmaceutical risk factor for chronic renal allograft rejection. Transplantation 1996: 62: 599-606.
14. GREVEL J, KAHAN BD. Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Clin Chem 1991: 37: 1905-1908.
15. DUNN S, COONEY G, SOMMERAUER J, et al. Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients. Transplantation 1997: 63: 1762-1767.
16. DUNN SP, COONEY GF, KULINSKY A, et al. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients. Transplantation 1995: 60: 1438-1442.
17. max) correlate with freedom from liver graft rejection: Results of a prospective, randomized comparison of Neoral and Sandimmune for liver transplantation (NOF-8). Transplantation 1999: 67: 1133-1137.
18. SINDI R, LA VIA MF, PAULLING E. Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine + rapamycin regimen. Transplantation 2000: 69: 432-436 (Abstr. no. 12).
19. GJERTSON DW, CECKA JM. Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry. Pediatr Transpl 2001: 5: 5-15.
20. ETTENGER RB, ROSENTHAL JT, MARIK JL, et al. Improved cadaveric renal transplant outcome in children. Pediatr Nephrol 1991: 5: 137-142.
21. COONEY GF, HABUCKY K, HOPPU K. Cyclosporine pharmacokinetics in pediatric transplant recipients. Clin Pharmacokinet 1997: 32: 481-495.
22. WHITINGTON P, EMOND J, WHITINGTON S, et al. Small-bowel length and the dose of Cyclosporine A in children after liver transplantation. N Engl J Med 1990: 322: 733-738.
23. HARMON WE, SULLIVAN EK. Cyclosporine dosing and its relationship to outcome in pediatric renal transplantation. Kidney Int Suppl 1993: 43: S50-S55.
24. MATAS AJ, GILLINGHAM KJ, CHAVERS BM, et al. The importance of early cyclosporine levels in pediatric kidney transplantation. Clin Transplant 1996: 10 (6 Part 1): 482-486.
25. HOYER PF, VESTER U. Refining immunosuppressive protocols in pediatric renal transplant recipients. Transplant Proc 2001: 33: 3587-3589.
26. FILLER G, MAI I, FILLER S, EHRICH JH. Abbreviated cyclosporine AUCs on Neoral - the search continues! Pediatr Nephrol 1999: 13: 98-102.
27. KELLES A, HERMAN J, TJANDRA-MAGA TB, VAN DAMMELOMBAERTS R. Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients. Pediatr Transpl 1999: 3: 282-287.
28. WIGGER M, DRUCKLER E, MUSCHEITES J. STOLPE HJ, KUNDT G, WACKE R. Cyclosporine peak concentration in relation to the four-hour absorption phase in pediatric renal graft recipients. Transplant Proc 2001: 33: 3126-3127.
29. DELLO STROLOGO L, CAMPAGNANO P, FEDERICI G, RIZZONI G. Cyclosporine A monitoring in children: Abbreviated area under curve formulas and C2 level. Pediatr Nephrol 1999: 13: 95-97.
30. DUNN S, FALKENSTEIN K, COONEY G. Neoral C (2) monitoring in pediatric liver transplant recipients. Transplant Proc 2001: 33: 3094-3095.